{"id":"W2604893395","doi":"10.3389/fonc.2017.00067","title":"Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer","year":2017,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Docetaxel; Nivolumab; Oncology; Atezolizumab; Lung cancer; Internal medicine; Chemotherapy; Cancer; Immunotherapy; Immune checkpoint; Targeted therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005353798,0.0005112864,0.002558767,0.0004256017,0.00007481623,0.00002729437,0.0001758147,0.0003801839,0.0000121344],"category_scores_gemma":[0.0000364914,0.0002887843,0.0003232914,0.0002819709,0.0002225584,0.00004700663,0.00002305373,0.0003486424,9.465859e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001466645,"about_ca_system_score_gemma":0.001331267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004270804,"about_ca_topic_score_gemma":0.001056297,"domain_scores_codex":[0.9975178,0.0003477311,0.0008846901,0.0005583579,0.0001861689,0.0005052986],"domain_scores_gemma":[0.9983538,0.0001931767,0.000793064,0.0005290212,0.00004595824,0.00008498435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003176893,0.00144328,0.0009419698,0.006400615,0.0004285938,0.0004857028,0.0009321364,8.358927e-7,0.000004285595,0.000002680903,0.000754243,0.9854288],"study_design_scores_gemma":[0.01056598,0.005775423,0.0003758601,0.006157122,0.001967468,0.00009291519,0.0002925584,0.00002290154,0.00006547212,0.00001771247,0.974381,0.0002856006],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009463216,0.9810029,0.00003558762,0.0002909409,0.0007502361,0.008018918,0.00006174143,0.00001506868,0.0003613352],"genre_scores_gemma":[0.0006537305,0.9896773,0.004023382,0.0001578064,0.00009713803,0.004689697,0.0002048109,0.00005288317,0.0004432326],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9851432,"threshold_uncertainty_score":0.9999564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0738078040686972,"score_gpt":0.4036445052378537,"score_spread":0.3298367011691565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}